Demethylation of promoter C region of estrogen receptor α gene is correlated with its enhanced expression in estrogen-ablation resistant MCF-7 cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 105, Issue 1-5, 2007, Pages 106-114

  Sogon, Tetsuya ^a,b   Masamura, Shigeru ^c   Hayashi, Shin ichi ^d   Santen, Richard J ^e   Nakachi, Kei ^a,b   Eguchi, Hidetaka ^a,b  

^a HIROSHIMA UNIVERSITY   (Japan)

^b RADIATION EFFECTS RESEARCH FOUNDATION   (Japan)

^c TOKYO DENTAL COLLEGE   (Japan)

^d TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

Breast cancer; Estrogen receptor ; Methylation

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR ALPHA; PRIMER DNA;

ARTICLE; CELL MEMBRANE; CELL STRAIN MCF 7; CONTROLLED STUDY; DEMETHYLATION; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PROMOTER A REGION; PROMOTER C REGION; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TISSUE CULTURE;

BASE SEQUENCE; BREAST NEOPLASMS; CELL LINE, TUMOR; DNA METHYLATION; DNA PRIMERS; ESTROGEN RECEPTOR ALPHA; ESTROGENS; HUMANS; MOLECULAR SEQUENCE DATA; POLYMERASE CHAIN REACTION; PROMOTER REGIONS (GENETICS); RNA, MESSENGER;

EID: 34547674955     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2006.12.104     Document Type: Article

References (26)

1. Jordan V.C. Selective estrogen receptor modulation: concept and consequences in cancer. Cancer Cell 5 3 (2004) 207-213
2. Yue W., Wang J.P., Li Y., Bocchinfuso W.P., Korach K.S., Devanesan P.D., Rogan E., Cavalieri E., and Santen R.J. Tamoxifen versus aromatase inhibitors for breast cancer prevention. Clin. Cancer Res. 11 2 (2005) 925-930
3. Santen R.J., and Harvey H.A. Use of aromatase inhibitors in breast carcinoma. Endocr. Relat. Cancer 6 1 (1999) 75-92
4. Santen R.J., Manni A., Harvey H.A., and Redmond C. Endocrine treatment of breast cancer in woman. Endocr. Rev. 11 2 (1990) 221-265
5. Masamura S., Santner S.J., Heitjan D.F., and Santen R.J. Estrogen deprivation causes estradiol hypersensitivity in human breast cancer cells. J. Clin. Endocrinol. Metab. 80 10 (1995) 2918-2925
6. Jeng M.H., Shupnik M.A., Bender T.P., Westin E.H., Bandyopadhyay D., Kumar R., Masamura S., and Santen R.J. Estrogen receptor expression and function in long-term estrogen-deprived human breast cancer cells. Endocrinology 139 10 (1998) 4164-4174
7. Song R.X., McPherson R.A., Adam L., Bao Y., Shupnik M., Kumar R., and Santen R.J. Linkage of rapid estrogen action to MAPK activation by ERα-Shc association and Shc pathway activation. Mol. Endocrinol. 16 1 (2002) 116-127
8. Zivadinovic D., and Watson C.S. Membrane estrogen receptor-α levels predict estrogen-induced ERK1/2 activation in MCF-7 cells. Breast Cancer Res. 7 1 (2005) 130-144
9. Yue W., Wang J.P., Conaway M., Masamura S., Li Y., and Santen R.J. Activation of the MAPK pathway enhances sensitivity of MCF-7 breast cancer cells to the mitogenic effort of estradiol. Endocrinology 143 9 (2002) 3221-3229
10. Zhang Z., Kumar R., Santen R.J., and Song R.X. The role of adapter protein Shc in estrogen non-genomic action. Steroids 69 8/9 (2004) 523-529
11. Santen R.J., Song R.X., Zhang Z., Kumar R., Jeng M.H., Masamura S., Lawrence J., Berstein L., and Yue W. Long-term estradiol deprivation in breast cancer cells up-regulates growth factor signaling and enhances estrogen sensitivity. Endocr. Relat. Cancer 12 Suppl. 1 (2005) 61-73
12. Koš M., Reid G., Denger S., and Gannon F. Minireview: genomic organization of the human ERα gene promoter region. Mol. Endocrinol. 15 12 (2001) 2057-2063
13. Flouriot G., Griffin C., Kenealy M., Sonntag-Buck V., and Gannon F. Differentially expressed messenger RNA isoforms of the human estrogen receptor-α gene are generated by alternative splicing and promoter usage. Mol. Endocrinol. 12 12 (1998) 1939-1954
14. Malyala A., Kelly M.J., and Rønnekleiv O.K. Estrogen modulation of hypothalamic neurons: activation of multiple signaling pathways and gene expression changes. Steroids 70 5-7 (2005) 397-406
15. Österlund K.M., Grandied K., Keller E., and Hurd Y.L. The human brain has distinct regional expression patterns of estrogen receptor α mRNA isoforms derived from alternative promoters. J. Neurochem. 75 4 (2000) 1390-1397
16. Hayashi S., Imai K., Suga K., Kurihara T., Higashi Y., and Nakachi K. Two promoters in expression of estrogen receptor messenger RNA in human breast cancer. Carcinogenesis 18 3 (1997) 459-464
17. Tanimoto K., Eguchi H., Yoshida T., Hajiro-Nakanishi K., and Hayashi S. Regulation of estrogen receptor α gene mediated by promoter B responsible for its enhanced expression in human breast cancer. Nucl. Acids Res. 27 3 (1999) 903-909
18. deConinck E.C., McPherson L.A., and Weigel R.J. Transcriptional regulation of estrogen receptor in breast carcinomas. Mol. Cell. Biol. 15 4 (1995) 2191-2196
19. McPherson L.A., Baichwal V.R., and Weigel R.J. Identification of ERF-1 as a member of the AP2 transcription factor family. Proc. Natl. Acad. Sci. U.S.A. 94 9 (1997) 4342-4347
20. Yoshida T., Eguchi H., Nakachi K., Tanimoto K., Higashi Y., Suemasu K., Iino Y., Morishita Y., and Hayashi S. Distinct mechanisms of loss of estrogen receptor α gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factor. Carcinogenesis 21 12 (2000) 2193-2201
21. Yoshida N., Omoto Y., Inoue A., Eguchi H., Kobayashi Y., Kurosumi M., Saji S., Suemasu K., Okazaki T., Nakachi K., Fujita T., and Hayashi S. Prediction of prognosis of estrogen receptor-positive breast cancer with combination of selective estrogen-regulated genes. Cancer Sci. 95 6 (2004) 496-502
22. Herman G.J., Graff R.J., MyöHänen S., Nelkin D.B., Baylim B.S., and Methylation-specific. PCR: a novel PCR assay for methylation status of CpG islands. Proc. Natl. Acad. Sci. U.S.A. 93 18 (1996) 9821-9826
23. Li L.C., and Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinfomatics 18 11 (2002) 1427-1431
24. Fasco M.J. Estrogen receptor mRNA splice variants produced from the distal and proximal promoter transcripts. Mol. Cell. Endocrinol. 138 (1998) 51-59
25. Weigel R.J., Crooks D.L., Iglehart J.D., and deConinck E.C. Quantitative analysis of the transcriptional start sites of estrogen receptors in breast carcinoma. Cell Growth Differ. 6 (1995) 707-711
26. Pentecost B.T., Song R., Luo M., DePasquale J.A., and Fasco M.J. Upstream regions of the estrogen receptor alpha proximal promoter transcript regulate ER protein expression through a translational mechanism. Mol. Cell Endocrinol. 229 (2005) 83-94